Last reviewed · How we verify

NCT04022577

Effects of Adherence Therapy on Medication Adherence in Patients With Schizophrenia Spectrum Disorder

Completed NA Last updated 7 March 2024
What this trial tests

NA trial testing Adherence Therapy in Motivational Interviewing in 120 participants. Completed in 30 September 2019.

Timeline
1 October 2018
Primary endpoint
30 August 2019
30 September 2019

Quick facts

Lead sponsorNational Yang Ming Chiao Tung University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment120
Start date1 October 2018
Primary completion30 August 2019
Estimated completion30 September 2019
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

National Yang Ming Chiao Tung University

Who can join

Adults 20 to 64, any sex, with Motivational Interviewing or Schizophrenia Spectrum Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will explore the effect of Adherence Therapy(AT) on medication adherence in patients with schizophrenia spectrum disorder.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Motivational Interviewing

Currently open trials in the same condition.

Other National Yang Ming Chiao Tung University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04022577.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing